FNY Partners Fund’s Loxo Oncology, Inc LOXO Stock Holding History

FNY Partners Fund’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500	Closed	-$46K	–	686
2017 Q3	$46K	Buy	+500	New	+$38.8K	0.01%	301

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

FNY Partners Fund's LOXO Position: Q4 2017 in Review

FNY Partners Fund sold out of Loxo Oncology, Inc (LOXO) in Q4 2017, closing a stake of 500 shares — an estimated $46K sold.

FNY Partners Fund first reported a position in LOXO in Q3 2017 and held it in 1 quarter. The position peaked at $46K in Q3 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

FNY Partners Fund reported no remaining Loxo Oncology, Inc position as of Q4 2017 after selling out during the quarter.
FNY Partners Fund sold 500 Loxo Oncology, Inc shares in Q4 2017, an estimated $46K.
FNY Partners Fund first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 1 quarter.
FNY Partners Fund's Loxo Oncology, Inc position peaked at $46K in Q3 2017.
141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.